Hospital Clinico Universitario San Carlos

Madrid 28040

2 studies enrolling now · 8 studies all time

What they study most

Central Nervous System Diseases, Colorectal Cancer, Diagnostic Self Evaluation, Gastroparesis, Heart Failure, Metastatic Castration-Resistant Prostate Cancer (mCRPC), Myasthenia Gravis, Solid Tumors Harboring Somatic HER2 or EGFR Exon 18 Mutations, Symptomatic Hypertrophic Cardiomyopathy (HCM)

Studies at this site

• A Non-interventional, Post-authorisation Safety Study of Patients Treated With Efgartigimod Alfa — Recruiting now
• Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of Aficamten in Adults With HCM — Enrolling by invitation
• A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Study of Fuzuloparib Combined With Abiraterone Acetate and Prednisone (AA-P) Versus Placebo Combined With AA-P as First-Line Treatment in Patients With Metastatic Castration-Resistant Prostate Cancer — Running, not enrolling
• Basket Study of Neratinib in Participants With Solid Tumors Harboring Somatic HER2 or EGFR Exon 18 Mutations — Stopped early
• Diabetic Gastroparesis Study 05 — Stopped early
• International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device — Stopped early
• Safety and Efficacy Evaluation of DOTAREM® in MRI of Central Nervous System (CNS) Lesions — Completed
• Efficacy and Safety of Simtuzumab (SIM) With FOLFIRI as Second Line Treatment in Colorectal Adenocarcinoma — Stopped early